| Median TNT/OS (months) |
---|
| TNT1/OS1a
| TNT2/OS2b
| TNT3/OS3c
| TNT4/OS4d
|
---|
LMS | 8.0/24.9 | 5.6/17.3 | 4.6/12.3 | 4.4/9.2 |
UPS | 4.8/11.0 | 3.5/7.9 | 2.3/3.7 | 3.5/6.2 |
DLPS | 4.4/11.8 | 5.1/8.8 | 2.4/6.0 | 3.2/8.5 |
SS | 8.7/19.7 | 5.7/11.7 | 3.4/7.8 | 2.3/6.0 |
MPNST | 4.1/12.5 | 2.8/7.0 | 3.6/8.0 | 3.7/5.4 |
-
aCalculated from the date of first-line treatment onset
-
bCalculated from the date of second-line treatment onset
-
cCalculated from the date of third-line treatment onset
-
dCalculated from the date of fourth-line treatment onset
-
DLPS dedifferentiated liposarcomas, LMS leiomyosarcomas, MPNST malignant peripheral nerve sheath sarcomas, SS synovial sarcomas, UPS undifferentiated pleomorphic sarcomas